Provided by Tiger Trade Technology Pte. Ltd.

Kamada

8.21
+0.19002.37%
Post-market: 8.210.00000.00%19:39 EST
Volume:30.51K
Turnover:248.55K
Market Cap:473.57M
PE:23.48
High:8.23
Open:8.03
Low:8.02
Close:8.02
52wk High:9.16
52wk Low:5.54
Shares:57.68M
Float Shares:9.36M
Volume Ratio:0.50
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3496
EPS(LYR):0.2500
ROE:7.86%
ROA:4.76%
PB:1.79
PE(LYR):32.84

Loading ...

Kamada Up Over 7%, on Track for Highest Close Since September 2020 -- Data Talk

Dow Jones
·
Jan 27

Hubspot Stock Set to Rise, Says Analyst. Plus, McGraw Hill, UHS, and More Stocks. -- Barrons.com

Dow Jones
·
Jan 10

Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance

GlobeNewswire
·
Jan 07

Kamada Secures $10-$14 Million Extension for Canadian Plasma-Derived Products Supply

Reuters
·
Dec 18, 2025

Kamada Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 09, 2025

Kamada to Discontinue Phase 3 Trial of Inhaled AAT: Shares Fall

MT Newswires Live
·
Dec 08, 2025

Kamada Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2026

GlobeNewswire
·
Dec 08, 2025

NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM

Reuters
·
Dec 08, 2025

Kamada Ltd. Amends Shareholder Meeting Notice and Voting Procedures

Reuters
·
Dec 02, 2025

Kamada’s Growth Potential and Strategic Development Justify Buy Rating

TIPRANKS
·
Nov 12, 2025

Kamada Ltd. Reports Strong Financial Growth in 2025

TIPRANKS
·
Nov 11, 2025

Kamada Ltd. Reports Strong Growth Amid Challenges

TIPRANKS
·
Nov 11, 2025

Kamada Q3 2025 Earnings Call Summary and Q&A Highlights: Strong Revenue Growth and Strategic Expansion

Earnings Call
·
Nov 10, 2025

Kamada (KMDA) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Nov 10, 2025

Kamada sees FY25 revenue $178M-$182M

TIPRANKS
·
Nov 10, 2025

Kamada Q3 EPS $0.09 Misses $0.10 Estimate, Sales $47.010M Beat $45.811M Estimate

Benzinga
·
Nov 10, 2025

Biopharma firm Kamada's Q3 revenue up 13%, beats estimates

Reuters
·
Nov 10, 2025

Press Release: Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth

Dow Jones
·
Nov 10, 2025

Kamada Ltd expected to post earnings of 9 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

Kamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation

TIPRANKS
·
Nov 04, 2025